Fig. 2.
Percent changes in markers of inflammation and immune activation.
Plasma samples were thawed and levels of A) soluble CD14 (sCD14), soluble CD163 (sCD163), B) C reactive protein (hsCRP), tumor necrosis factor receptor type 1 (TNFr-I), D-dimer, interleukin-6 (IL-6) and C) lipoprotein-associated phospholipase A2 (Lp-PLA2) were measured by ELISA. Differences in percent changes were assessed by Wilcoxon rank-sum test.